RxDoctor Payments Data

Joshua Bowers, MD

Family Medicine · Canton, ILNPI 1194947002

Payments from drug & device makers

$8,579in general payments, 2019–2025

Across 455 payments — averaging $18.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sioux Surgical Inc$1K
  • Boehringer Ingelheim$1K
  • AbbVie$737
  • AstraZeneca$726
  • Bayer$664
  • GSK$521
  • plus $4K from 37 others

What the payments were for

  • Food & beverage$7,37986%
  • Education$1,20014%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$8,579 in reported general payments places this provider in the 95th percentile of 4,116 family medicine providers in Illinois.

See all family medicine providers in Illinois

Medicare billing

Part B allowed, 2024
$25,353
Medicare patients
86
Services billed
358

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin203$186,846
EliquisApixaban315$170,294
TrulicityDulaglutide104$106,487
OzempicSemaglutide82$83,380
FarxigaDapagliflozin Propanediol60$58,899
MyrbetriqMirabegron115$58,512
XareltoRivaroxaban71$51,400
JanuviaSitagliptin Phosphate41$39,753
Trelegy ElliptaFluticasone/Umeclidin/Vilanter46$37,509
LinzessLinaclotide57$37,407
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl203$31,079
KerendiaFinerenone33$30,608
RybelsusSemaglutide16$23,386
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog55$20,780
VraylarCariprazine Hcl11$20,487

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Spiriva Respimat, Stiolto Respimat$1,147$201,731226 claims
PfizerEliquis, Nurtec Odt$485$180,216326 claims
Lilly USA, LLCTrulicity, Mounjaro$477$123,668121 claims
Novo NordiskOzempic, Rybelsus$420$106,76698 claims
GSKTrelegy Ellipta, Incruse Ellipta, Anoro Ellipta, Breo Ellipta$521$79,425126 claims
AstraZenecaFarxiga, Breztri Aerosphere, Symbicort$726$77,12499 claims
Astellas Pharma US IncMyrbetriq$277$58,512115 claims
AbbVieLinzess, Vraylar$737$57,89468 claims
Johnson & JohnsonXarelto$30$51,40071 claims
MerckJanuvia$14$39,75341 claims
BayerKerendia$664$30,60833 claims
Orexo US, Inc.Zubsolv$95$10,66812 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 4,116 family medicine providers in Illinois.

Other family medicine in Canton

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →